GHRS — GH Research PLC stock price, charts and financials

QT89GH Research PLC

GH Research PLC (NASDAQ: GHRS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.26
-0.46-1.60%
GHRSQT89GH Research PLC·NASDAQ
28.26-1.60%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Sep 11, 20266-KForeign issuer report
Sep 09, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 06, 20266-KForeign issuer report
Jun 26, 20266-KForeign issuer report
Jun 04, 20266-KForeign issuer report
May 21, 20266-KForeign issuer report
May 19, 2026EFFECTNotice of effectiveness
May 18, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20266-KForeign issuer report
May 14, 2026424B5Prospectus
May 14, 2026F-3F-3
May 14, 20266-KForeign issuer report
May 13, 20266-KForeign issuer report
May 13, 20266-KForeign issuer report
Apr 30, 20266-KForeign issuer report
Apr 29, 2026424B5Prospectus
Apr 17, 20263Initial statement of beneficial ownership
Apr 02, 20263Initial statement of beneficial ownership
Apr 02, 20263Initial statement of beneficial ownership